RPCEC00000005
已完成
2 期
Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2
Center of Pharmaceutical Chemistry0 个研究点目标入组 20 人2009年3月13日
适应症Spinocerebellar Hereditary Ataxia Type 2Spinocerebellar AtaxiasCerebellar AtaxiaAtaxiaSpinocerebellar DegenerationsCerebellar DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesSpinal Cord DiseasesDyskinesiasNeurologic ManifestationsGenetic Diseases, InbornBrain Diseases
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Spinocerebellar Hereditary Ataxia Type 2
- 发起方
- Center of Pharmaceutical Chemistry
- 入组人数
- 20
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.Patients with diagnosis of SCA2 of any sex from 18 up to 60 years old, both inclusive.
- •2\. Patient able to develop basic activities of the daily life with independence (according to Barthel scale).
- •3\. Time of evolution of the illness until or smaller than 15 years.
- •4\. Patient that voluntarily accept to participate in the clinical trial, by means of the signature of the informed consent.
排除标准
- •1\.Patients with antecedents of alcoholism.
- •2\. Patients with antecedents of any other illness with repercussion in the nervous system.
- •3\. Patient with non controlled chronic illnesses.
- •4\. Pregnancy or nursing.
- •5\. Patient with renal or hepatic failure.
- •6\. Patients with inmunosupresores tratment or with other antioxidant treatment.
- •7\. Patients that participate in another clinical trial.
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
Brain protection in Intracranial Aneurysm surgeryHealth Condition 1: I671- Cerebral aneurysm, nonrupturedCTRI/2022/07/044141Aparna S Nair
招募中
2 期
europrotective Effects of Stingless Bee Honey (Trigona spp) Supplementation on Halting Vascular Mild Cognitive Impairment among Post-Stroke PatientsVascular Mild Cognitive Impairment among Post-Stroke PatientsStroke, Vascular Mild Cognitive ImpairmentTCTR20230320003niversiti Sains Malaysia90
已完成
不适用
Assessing the neuro-protective effect of mild cooling in neonates receiving extra-corporeal membrane oxygenation (ECMO)ISRCTN72635512niversity Hospitals of Leicester NHS Trust (UK)118
进行中（未招募）
1 期
A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis - Neuroprotection with lamotrigine in multiple sclerosisMultiple sclerosisEUCTR2005-001949-42-GBniversity College London120
尚未招募
2 期
Investigation of preventive effect with neurotropin for neuropathy due to paclitaxelThe patient of gynecologic cancer treated with paclitaxelJPRN-UMIN000012211Department of Obstetrics and Gynecology, The University of Tokushima50